Skip to main content

Advertisement

Log in

Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Oropharyngeal candidiasis (OPC) is a major cause of morbidity in patients with malignancies. It is a common complication of head and neck radiation therapy and can result in pain, dysgeusia (taste changes), anorexia, malnutrition, and esophageal or systemic dissemination. Clinicians should be aware of current epidemiology, elements of diagnosis, and therapeutic trials guiding the recent recommendations for prophylaxis and management of OPC, a disease often incorrectly perceived as benign.

Methods

This review discusses OPC with focus in head and neck cancer patients receiving radiotherapy.

Results

Local treatments are recommended as first-line therapy in milder forms of OPC. In the setting of local therapy, products that provide prolonged contact time and are not sucrose sweetened may result in successful prevention and management with low risk of oral/dental complications.

Conclusion

Diagnosis and management of OPC is required in head and neck cancer patients treated with radiation. Local therapy is suggested as first-line treatment for OPC, unless severe clinical infection or high risk immune suppression necessitate systemic therapy. The availability of effective locally delivered (topical) medications may provide potential for prophylaxis for carriers of Candida species in head and cancer patients during radiation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Al-Attas SA, Amro SO (2010) Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients. Ann Saudi Med 30:101–108

    Article  PubMed  Google Scholar 

  2. Barchiesi F, Maracci M, Radi B, Arzeni D, Baldassarri I, Giacometti A, Scalise G (2002) Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J Antimicrob Chemother 50:999–1002

    Article  PubMed  CAS  Google Scholar 

  3. Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C, Destouni E, Antoniades D (2004) Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol 19:347–351

    Article  PubMed  CAS  Google Scholar 

  4. Bensadoun RJ, Daoud D, Bastit L, El Gueddari B, Allavena C, Benidder A, Gourmet R (2008) Comparison of the efficacy and safety of miconazole Lauriad® tablets to those of miconazole gel in the treatment of oropharyngeal candidiasis: a controlled multicenter, randomised, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer 112:204–211

    Article  PubMed  CAS  Google Scholar 

  5. Bensadoun RJ, Franquin JC, Ciais G, Darcourt V, Schubert MM, Viot M, Dejou J, Tardieu C, Benezery K, Nguyen TD, Laudoyer Y, Dassonville O, Poissonnet G, Vallicioni J, Thyss A, Hamdi M, Chauvel P, Demard F (1999) Low energy He/Ne laser in the prevention of radiation-induced mucositis: a multicenter phase III randomized study for patients with head and neck cancer. Support Care Cancer 7:244–252

    Article  PubMed  CAS  Google Scholar 

  6. Bensadoun RJ, Magné N, Marcy PY, Demard F (2001) Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment. Eur Arch Otorhinolaryngol 258:481–487

    Article  PubMed  CAS  Google Scholar 

  7. Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O (2006) Fluconazole for the management of invasive candidiasis: where do we stand after 15 years ? J Antimicrob Chemother 57:384–410

    Article  PubMed  CAS  Google Scholar 

  8. Clarkson JE, Worthington HV, Eden OB (2007) Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev (1):CD003807

  9. Coleman D, Sullivan D, Harrington B, Haynes K, Henman M, Shanley D, Shanley D, Bennett D, Moran G, McCreary C, O'Neill L (1997) Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis 3:96–101

    Google Scholar 

  10. Corvo R, Amichetti M, Ascarelli A, Arcangeli G, Buffoli A, Cellini N, Cionini L, De Renzis C, Emiliani E, Franchini P, Gabriele P, Gobitti C, Grillo Ruggieri F, Bertoni F, Magrini SM, Marmiroli L, Orsatti M, Panizza GM, Tordiglione M, Ziccarelli L, Gava A, Zorat PL, Ghelfi R, Serra GF, Vitale V (2008) Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. Eur J Cancer Care 17:270–277

    Article  CAS  Google Scholar 

  11. Dahiya MC, Redding SW, Dahiya RS, Eng TY, Kirkpatrick WR, Coco BJ, Sadkowski LC, Fothergill AW, Waite A, Rinaldi MG, Patterson TF, Thomas CR (2003) Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 1:79–83

    Google Scholar 

  12. Davies AN, Brailsford S, Broadley K, Beighton D (2002) Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol 17:79–84

    Article  PubMed  CAS  Google Scholar 

  13. Davies AN, Brailsford SR, Beighton D (2006) Oral candidosis in patients with advanced cancer. Oral Oncol 42:698–702

    Article  PubMed  Google Scholar 

  14. De Repentigny L, Lewandowski D, Jolicoeur P (2004) Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 17:729–759

    Article  PubMed  Google Scholar 

  15. Dupont B (2005) A prospective non comparative study evaluating tolerance and efficacy of miconazole muco-adhesive tablet (Loramyc*) for oral candidiasis in HIV patients. Clinical overview/study BA2002/01/03 (Dossier d’AMM, Miconazole Lauriad*, Sept.)

  16. Ellepola AN, Samaranayake LP (2001) Adjunctive use of chlorhexidine in oral candidoses: a review. Oral Dis 7:11–17

    Article  PubMed  CAS  Google Scholar 

  17. Epstein JB, Freilich MM, Le ND (1993) Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 76:169–174

    Article  PubMed  CAS  Google Scholar 

  18. Epstein JB, Gorsky M, Caldwell J (2002) Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:671–675

    Article  PubMed  Google Scholar 

  19. Finlay PM, Richardson MD, Robertson AG (1996) A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours. Br J Oral Maxillofac Surg 34:23–25

    Article  PubMed  CAS  Google Scholar 

  20. Havlir DV, Dube MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC Jr, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA (1998) Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clin Infect Dis 27:1369–1375

    Article  PubMed  CAS  Google Scholar 

  21. Jham BC, Franca EC, Oliveira RR, Santos VR, Kowalski LP, da Silva Freire AR (2007) Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:355–358

    Article  PubMed  Google Scholar 

  22. Jham BC, Reis PM, Miranda EL, Lopes RC, Carvalho AL, Scheper MA, Freire AR (2008) Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig 12:19–24

    Article  PubMed  Google Scholar 

  23. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, Mcguire DB, Hutchins R, Peterson DE, Michelet M, Avritcher E, Jones J, Anthony L, Bowen J, Garden A, Hewson I, Spijkervet F, Logan R, Von Bültzingslöwen I, Brennan M, Stringer A, Barasch A, Damato K, Elad S, Altman A, Oberle-Edwards L, Johnson J, Wienandts P, Correa E, Bensadoun R-J, Lalla RV (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 169:820–831

    Article  Google Scholar 

  24. Kinirons MJ, Fleming P, Boyd D (1995) Dental caries experience of children in remission from acute lymphoblastic leukaemia in relation to the duration of treatment and the period of time in remission. Int J Paediatr Dent 5:169–172

    Article  PubMed  CAS  Google Scholar 

  25. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D’Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, Patton LL, Elting LS, Spijkervet FKL, Brennan MT (2010) A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 18:985–992

    Article  PubMed  Google Scholar 

  26. Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin North Am 52:61–67

    Article  PubMed  Google Scholar 

  27. Lass-Florl C, Gunsilius E, Gastl G, Englisch M, Koch G, Ulmer H, Dierich MP, Petzer A (2003) Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol 82:565–569

    Article  PubMed  CAS  Google Scholar 

  28. Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, Cornely OA, Patino H, Black TA (2009) Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. Antimicrob Agents Chemother 53:5026–5034

    Article  PubMed  CAS  Google Scholar 

  29. Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A, Dardoufas K, Kouloulias V, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanicolaou VS, Kouvaris J (2006) Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer 14:44–51

    Article  PubMed  Google Scholar 

  30. Pagani JL, Chave JP, Casjka C, Glauser MP, Bille J (2002) Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 50:231–240

    Article  PubMed  CAS  Google Scholar 

  31. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg B-J, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 1:503–535

    Article  Google Scholar 

  32. Peterson DE (2006) New strategies for management of oral mucositis in cancer patients. J Supportive Oncol 4:9–13

    CAS  Google Scholar 

  33. Peterson DE, Bensadoun R-J, Roila F (2008) Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations. Ann Oncol 19(Suppl 2):122–125

    Google Scholar 

  34. Phillips SM, Dellinger TM (2005) Dental decay due to xerostomia and nystatin. Ann Pharmacother 39:1758

    Article  PubMed  Google Scholar 

  35. Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G (1993) Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. J Antimicrob Chemother 31:973–984

    Article  PubMed  CAS  Google Scholar 

  36. Ramirez-Amador V, Silverman S Jr, Mayre P, Tyler M, Quivey J (1997) Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Oral Pathol Oral Radiol Endod 84:149–153

    Article  CAS  Google Scholar 

  37. Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, Rinaldi MG, Thomas CR (2004) Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:47–52

    Article  PubMed  Google Scholar 

  38. Redding SW, Kirkpatrick WR, Coco BJ, Sadkowski L, Fothergill AW, Rinaldi MG, Eng TY, Patterson TF (2002) Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol 40:1879–1881

    Article  PubMed  Google Scholar 

  39. Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fothergill AW, Lopez-Ribot JL, Bailey CW, Rinaldi MG, Patterson TF (1999) Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37:3896–3900

    PubMed  CAS  Google Scholar 

  40. Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on antifungal susceptibility testing of the national committee for clinical laboratory standards. Clin Infect Dis 24:235–247

    Article  PubMed  CAS  Google Scholar 

  41. Ruhnke M (2006) Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr Drug Targets 7:495–504

    Article  PubMed  CAS  Google Scholar 

  42. Scully C, el-Kabir M, Samaranayake LP (1994) Candida and oral candidosis: a review. Crit Rev Oral Biol Med 5:125–157

    PubMed  CAS  Google Scholar 

  43. Soysa NS, Ellepola AN (2005) The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis 11:268–273

    Article  PubMed  CAS  Google Scholar 

  44. Soysa NS, Samaranayake LP, Ellepola AN (2004) Cytotoxic drugs, radiotherapy and oral candidiasis. Oral Oncol 40:971–978

    Article  PubMed  CAS  Google Scholar 

  45. Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1998) Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 34:123–126

    Article  PubMed  CAS  Google Scholar 

  46. World Health Organization (1979) Handbook for reporting results of cancer treatment. World Health Organization, Geneva, pp 15–22

    Google Scholar 

  47. Worthington HV, Clarkson JE, Eden OB (2007) Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev (2):CD001972

  48. Zadik Y, Burnstein S, Derazne E, Sandler V, Ianculovici C, Halperin T (2010) Colonization of Candida: prevalence among tongue-pierced and non-pierced immunocompetent adults. Oral Dis 16:172–175

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rene-Jean Bensadoun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bensadoun, RJ., Patton, L.L., Lalla, R.V. et al. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer 19, 737–744 (2011). https://doi.org/10.1007/s00520-011-1154-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-011-1154-4

Keywords

Navigation